3SBio Inc. Schedules 2008 Second Quarter Earnings Release

SHENYANG, China, July 29 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release unaudited financial results for the second quarter ended June 30, 2008 after the US market closes on Tuesday, August 12, 2008.

The earnings release will be available on the investor relations page of its website at: http://www.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64

Following the earnings announcement, 3SBio Inc. senior management will host a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) on Wednesday, August 13, 2008 to discuss its 2008 second quarter financial results and recent business activity. The conference call may be accessed by calling (US) +1 480 629 9041 / (UK) +44 (0) 20 8515 2301 / (HK) +852 3009 5027. A telephone replay will be available shortly after the call until August 27, 2008 at (US) +1 303 590 3030/ (UK) +44 (0)20 7154 2833, Passcode: 3906839; and (HK) +852 2287 4304, Passcode: 098110#.

A live webcast of the conference call and replay will be available on the investor relations page of 3SBio's website at: http://www.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64 .

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

For more information, please visit 3SBio on the web at: http://www.3sbio.com .

CONTACT: Investor Contact: Kevin Teo, CFO of 3SBio Inc. at +86-24-2581-
1820; Investor Relations (US): Mahmoud Siddig of Taylor Rafferty at +1-212-
889-4350; Investor Relations (HK): Ruby Yim of Taylor Rafferty at
+852-3196- 3712; Media Contact: Jason Marshall of Taylor Rafferty at
+1-212-889-4350 all for 3SBio Inc.

Web site: http://www.3sbio.com/